On this week’s 51%, a genocide survivor tells her story that began in Bosnia and crossed into the U.S. Plus, a filmmaker explores new...
On this week’s 51%, we recognize the 25th anniversary of the Food & Drug Administration’s approval of mifepristone, which, in conjunction with misoprostol, is...
On this week’s 51%, we wrap our series on women in business. Harvard economist Claudia Goldin explains how women persisted in the job market...